rs1572312 — NFIA-AS2

Long non-coding RNA regulating erythropoiesis, influencing hemoglobin levels and oxygen transport capacity in endurance athletes

See your personal result for NFIA-AS2

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

NFIA-AS2 — The Elite Endurance Variant

The NFIA-AS2 gene encodes a long non-coding RNA11 long non-coding RNA
lncRNAs regulate gene expression without being translated into proteins, often controlling nearby genes through various mechanisms that regulates the NFIA transcription factor, which plays a crucial role in determining whether hematopoietic stem cells become red blood cells or white blood cells. This SNP, rs1572312, was discovered through a genome-wide association study22 genome-wide association study
GWAS: unbiased screen of the entire genome to identify genetic variants associated with a trait of elite Russian endurance athletes and represents one of the most statistically significant genetic markers for endurance performance yet identified.

The C allele at this position dramatically increases the likelihood of elite endurance athlete status. Among Olympic medalists in endurance events, 100% carried at least one C allele, with the CC genotype reaching 100% frequency — compared to just 78.6% in the general Russian population. This makes it one of the strongest genetic predictors of endurance capacity discovered to date.

The Mechanism

NFIA-AS2 is an antisense RNA33 antisense RNA
Antisense RNAs are transcribed from the opposite strand of a gene and can regulate that gene's expression through various mechanisms positioned within the first intron of the NFIA gene. By regulating NFIA expression, it influences a critical developmental decision: the choice between erythroid (red blood cell) and granulocytic (white blood cell) lineages during hematopoiesis44 hematopoiesis
Blood cell formation from hematopoietic stem cells in the bone marrow.

When NFIA is upregulated55 NFIA is upregulated
Research shows NFIA is markedly upregulated in erythroid cells while suppressed in granulocytic cells, it accelerates erythropoiesis — the production of red blood cells — while simultaneously suppressing granulopoiesis. This shifts the balance toward greater red blood cell production. NFIA also controls beta-globin expression66 controls beta-globin expression
NFIA regulates the developmental switch from fetal to adult hemoglobin and the transition from fetal to adult hemoglobin, ensuring efficient oxygen transport in adult erythrocytes.

The rs1572312 variant sits in an intron of this regulatory RNA, likely affecting either its expression level, stability, or regulatory activity. The C allele appears to enhance the pro-erythropoietic signal, leading to higher baseline red blood cell production, increased hemoglobin mass, and greater oxygen-carrying capacity — all critical determinants of endurance performance.

The Evidence

The initial GWAS77 initial GWAS
Ahmetov II et al. Genome-wide association study identifies three novel genetic markers associated with elite endurance performance. Biol Sport, 2015 examined 1,140,419 SNPs in 80 elite Russian endurance athletes (Olympic-level competitors in cross-country skiing, rowing, and long-distance running) and validated findings in 218 endurance athletes versus 1,789 controls across Russian and European populations. The C allele frequency was 95.5% in elite endurance athletes compared to 89.8% in non-elite endurance athletes (P = 0.026), 88.8% in Russian controls (P = 0.007), 90.6% in European controls (P = 0.020), and 86.2% in power athletes (P = 0.0005).

The most striking finding: all 20 Olympic medalists in the study carried the CC genotype (100% vs 78.6% in controls, P = 0.021). No other genetic variant in exercise genomics has shown such strong association with elite status.

A follow-up study in 238 well-trained athletes88 follow-up study in 238 well-trained athletes
Malczewska-Lenczowska J et al. HIF-1α and NFIA-AS2 polymorphisms as potential determinants of total hemoglobin mass in endurance athletes. J Strength Cond Res, 2022 examined the physiological mechanism. Athletes with the CC genotype had significantly higher: - Total hemoglobin mass (tHbmass) in female athletes and cyclists - Plasma volume and blood volume in cyclists - Erythrocyte volume in male athletes and cyclists - Aerobic performance measures in male cyclists

The genotype distribution varied by sport: male cyclists showed substantially higher A allele frequency compared to rowers and distance runners, suggesting different optimal genetic profiles for different endurance disciplines.

Practical Actions

Total hemoglobin mass is one of the strongest physiological determinants of VO2max99 VO2max
Maximal oxygen uptake, the gold standard measure of aerobic fitness, explaining 60-80% of individual variation in elite athletes. The NFIA-AS2 CC genotype provides a fundamental advantage in oxygen transport capacity through increased red blood cell production.

For individuals with the CC genotype, this translates to naturally higher hemoglobin levels and potentially superior response to endurance training and altitude exposure. For those with CA or AA genotypes, the lower baseline hemoglobin mass can be partially compensated through strategic training approaches: altitude training (natural or simulated), heat acclimatization protocols that stimulate plasma volume expansion, and ensuring optimal iron status to maximize the efficiency of existing erythropoiesis.

Regardless of genotype, regular monitoring of hemoglobin levels1010 monitoring of hemoglobin levels
Complete blood count (CBC) with hemoglobin, hematocrit, and red blood cell count and iron status1111 iron status
Serum ferritin, iron, total iron binding capacity, and transferrin saturation is essential for endurance athletes, as the demands of high-volume training can deplete iron stores and suppress erythropoiesis even in genetically advantaged individuals.

Interactions

NFIA-AS2 rs1572312 operates in the same biological pathway as other endurance-related variants but at a different level. While ACTN3 R577X1212 ACTN3 R577X
rs1815739 affects muscle fiber type composition and PPARGC1A Gly482Ser1313 PPARGC1A Gly482Ser
rs8192678 influences mitochondrial biogenesis, NFIA-AS2 controls the oxygen transport system itself — the supply side of the aerobic equation.

These variants likely show additive or synergistic effects: having favorable alleles at all three loci would combine efficient muscle contractile properties (ACTN3 XX for endurance), abundant mitochondria (PPARGC1A GG), and superior oxygen delivery (NFIA-AS2 CC). Conversely, unfavorable combinations might create mismatches — abundant mitochondria but insufficient oxygen delivery, or high oxygen-carrying capacity but poor muscular oxidative capacity.

The variant may also interact with altitude training response. Individuals with the CC genotype may experience greater hemoglobin mass increases during altitude exposure due to enhanced baseline erythropoietic capacity, though this hypothesis requires direct experimental testing.

Genotype Interpretations

What each possible genotype means for this variant.

CC Enhanced Erythropoiesis Beneficial

Genetically superior oxygen transport capacity

The CC genotype at rs1572312 enhances the activity of the NFIA-AS2 regulatory RNA, which in turn upregulates the NFIA transcription factor that directs hematopoietic stem cells toward the erythroid (red blood cell) lineage. This results in measurably higher total hemoglobin mass — the single best predictor of VO2max in trained athletes.

In the validation study of 238 endurance athletes, CC carriers showed significantly elevated hemoglobin content, red blood cell count, and reticulocyte count (young red blood cells, indicating active erythropoiesis). This translates directly to performance: greater oxygen delivery to working muscles during sustained aerobic exercise.

The genetic advantage is most pronounced in pure endurance disciplines (distance running, cross-country skiing, road cycling) where oxygen transport is the primary limiting factor. In sports requiring mixed qualities (middle distance, team sports with endurance components), the advantage persists but may be smaller.

GG Enhanced Erythropoiesis Beneficial

Genetically superior oxygen transport capacity

The CC genotype at rs1572312 enhances the activity of the NFIA-AS2 regulatory RNA, which in turn upregulates the NFIA transcription factor that directs hematopoietic stem cells toward the erythroid (red blood cell) lineage. This results in measurably higher total hemoglobin mass — the single best predictor of VO2max in trained athletes.

In the validation study of 238 endurance athletes, CC carriers showed significantly elevated hemoglobin content, red blood cell count, and reticulocyte count (young red blood cells, indicating active erythropoiesis). This translates directly to performance: greater oxygen delivery to working muscles during sustained aerobic exercise.

The genetic advantage is most pronounced in pure endurance disciplines (distance running, cross-country skiing, road cycling) where oxygen transport is the primary limiting factor. In sports requiring mixed qualities (middle distance, team sports with endurance components), the advantage persists but may be smaller.

AC Moderate Erythropoiesis Intermediate

Intermediate oxygen transport capacity with room for optimization

The heterozygous CA genotype shows intermediate effects on total hemoglobin mass and red blood cell production. In the athlete cohort, CA carriers had hemoglobin levels between CC homozygotes and AA carriers, consistent with an additive genetic effect.

While you don't have the maximal genetic predisposition for erythropoiesis, total hemoglobin mass is highly trainable. Altitude training can increase hemoglobin mass by 3-6%, heat acclimatization can expand plasma volume by 10-15%, and optimizing iron status ensures your existing erythropoietic machinery operates at full capacity. These interventions may be even more important for CA carriers, as they can compensate for the lack of two C alleles.

Your genotype also suggests checking whether your endurance limitations stem from central (oxygen transport) or peripheral (muscular oxidative capacity) factors. If VO2max testing reveals relatively low hemoglobin-normalized values, altitude training and iron optimization become priorities. If normalized VO2max is good, focus on peripheral adaptations (mitochondrial density, capillarization, substrate utilization).

GT Moderate Erythropoiesis Intermediate

Intermediate oxygen transport capacity with room for optimization

The heterozygous CA genotype shows intermediate effects on total hemoglobin mass and red blood cell production. In the athlete cohort, CA carriers had hemoglobin levels between CC homozygotes and AA carriers, consistent with an additive genetic effect.

While you don't have the maximal genetic predisposition for erythropoiesis, total hemoglobin mass is highly trainable. Altitude training can increase hemoglobin mass by 3-6%, heat acclimatization can expand plasma volume by 10-15%, and optimizing iron status ensures your existing erythropoietic machinery operates at full capacity. These interventions may be even more important for CA carriers, as they can compensate for the lack of two C alleles.

Your genotype also suggests checking whether your endurance limitations stem from central (oxygen transport) or peripheral (muscular oxidative capacity) factors. If VO2max testing reveals relatively low hemoglobin-normalized values, altitude training and iron optimization become priorities. If normalized VO2max is good, focus on peripheral adaptations (mitochondrial density, capillarization, substrate utilization).

AA Standard Erythropoiesis Reduced

Lower genetic predisposition for hemoglobin mass, compensate through training and nutrition

The AA genotype is associated with reduced activity of the NFIA-AS2 regulatory RNA, resulting in less NFIA-driven erythropoiesis. In practical terms, this likely means lower baseline hemoglobin levels, reduced total hemoglobin mass, and potentially smaller VO2max values relative to muscle mass.

This represents a measurable disadvantage for elite endurance competition, where differences of 2-3% in hemoglobin mass can separate podium finishers. However, it does not preclude recreational or even competitive endurance performance. Total hemoglobin mass can be increased 3-6% through altitude training, plasma volume can expand 10-15% through heat acclimatization, and optimizing iron status ensures maximal efficiency of erythropoiesis.

The AA genotype also highlights the importance of other physiological systems: muscular oxidative capacity (mitochondrial density, capillary density, enzyme activities), running economy or cycling efficiency, lactate threshold, and substrate utilization. These factors can partially compensate for lower oxygen-carrying capacity. Focus training on peripheral adaptations alongside central cardiovascular development.

Additionally, consider that endurance sports vary in their oxygen transport demands. Pure aerobic events (marathon, ultra-distance, long-distance triathlon) are most sensitive to hemoglobin mass. Events with anaerobic components (1500m, 5K, criterium cycling) are less affected. Choose event distances that align with your physiological strengths.

TT Standard Erythropoiesis Reduced

Lower genetic predisposition for hemoglobin mass, compensate through training and nutrition

The AA genotype is associated with reduced activity of the NFIA-AS2 regulatory RNA, resulting in less NFIA-driven erythropoiesis. In practical terms, this likely means lower baseline hemoglobin levels, reduced total hemoglobin mass, and potentially smaller VO2max values relative to muscle mass.

This represents a measurable disadvantage for elite endurance competition, where differences of 2-3% in hemoglobin mass can separate podium finishers. However, it does not preclude recreational or even competitive endurance performance. Total hemoglobin mass can be increased 3-6% through altitude training, plasma volume can expand 10-15% through heat acclimatization, and optimizing iron status ensures maximal efficiency of erythropoiesis.

The AA genotype also highlights the importance of other physiological systems: muscular oxidative capacity (mitochondrial density, capillary density, enzyme activities), running economy or cycling efficiency, lactate threshold, and substrate utilization. These factors can partially compensate for lower oxygen-carrying capacity. Focus training on peripheral adaptations alongside central cardiovascular development.

Additionally, consider that endurance sports vary in their oxygen transport demands. Pure aerobic events (marathon, ultra-distance, long-distance triathlon) are most sensitive to hemoglobin mass. Events with anaerobic components (1500m, 5K, criterium cycling) are less affected. Choose event distances that align with your physiological strengths.